Quantitation of 4-oxo-4-(3-pyridyl)butanoic acid and enantiomers of 4- hydroxy-4-(3-pyridyl)butanoic acid in human urine: A substantial pathway of nicotine metabolism

Chemical Research in Toxicology

Volumn 12, Issue 2, 1999, Pages 172-179

  Hecht, Stephen S ^a   Hatsukami, Dorothy K ^b   Bonilla, Leo E ^a   Hochalter, J Bradley ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID DERIVATIVE; HYDROXYACID; NICOTINE;

ARTICLE; CONTROLLED STUDY; ENANTIOMER; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; SMOKING; STEREOCHEMISTRY; TOXICOKINETICS; URINALYSIS; URINE LEVEL;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HYDROXYBUTYRATES; KETO ACIDS; NICOTINE; PYRIDINES; RATS; STEREOISOMERISM;

NICOTIANA TABACUM;

EID: 0033012856     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx980214i     Document Type: Article

References (20)

1. Trushin, N., and Hecht, S. S. (1999) Stereoselective metabolism of nicotine and tobacco-specific N-nitrosamines to 4-hydroxy-4-(3-pyridyl)butanoic acid in rats. Chem. Res. Toxicol. 12, 164-171.
2. Adams, J. D., O'Mara-Adams, K. J., and Hoffmann, D. (1987) Toxic and carcinogenic agents in undiluted mainstream smoke and sidestream smoke of different types of cigarettes. Carcinogenesis 8, 729-731.
3. Tricker, A. R., Ditrich, C., and Preussmann, R. (1991) N-Nitroso compounds in cigarette tobacco and their occurrence in mainstream tobacco smoke. Carcinogenesis 12, 257-261.
4. Hecht, S. S. (1998) Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol. 11, 559-603.
5. McKennis, H., Schwartz, S. L., Turnbull, L. B., Tamaki, E., and Bowman, E. R. (1964) The metabolic formation of γ-(3-pyridyl)-γ-hydroxybutyric acid and its possible intermediary role in the mammalian metabolism of nicotine. J. Biol. Chem. 239, 3981-3989.
6. Hecht, S. S., Carmella, S. G., Chen, M., Koch, J. F. D., Miller, A. T., Murphy, S. E., Jensen, J. A., Zimmerman, C. L., and Hatsukami, D. K. (1999) Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res. (in press).
7. 2 in humans. Biol. Mass Spectrom. 20, 247-252.
8. Curvall, M., Elwin, C. E., Kazemi-Vala, E., Warholm, C., and Enzell, C. R. (1990) The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers. Eur. J. Clin. Pharmacol. 38, 281-2870.
9. Gupta, S. K., Hwang, S. S., Causey, D., Rolf, C. N., and Gorsline, J. (1995) Comparison of the nicotine pharmacokinetics of nicoderm (nicotine transdermal system) and half-hourly cigarette smoking. J. Clin. Pharmacol. 35, 985-989.
10. Benowitz, N. L., Jacob, P., Fong, I., and Gupta, S. (1994) Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J. Pharmacol. Exp. Ther. 268, 296-303.
11. Ahmed, N. K., Felsted, R. L., and Bachur, N. R. (1979) Comparison and characterization of mammalian xenobiotic ketone reductases. J. Pharmacol. Exp. Ther. 209, 12-19.
12. Schepers, G., Rustemeier, K., Walk, R.-A., and Hackenberg, U. (1993) Metabolism of S-nicotine in non-induced and Aroclor-induced rats. Eur. J. Drug Metab. Pharmacokinet. 18, 187-197.
13. Kyerematen, G. A., Taylor, L. H., deBethizy, J. D., and Vesell, E. S. (1988) Pharmacokinetics of nicotine and 12 metabolites in the rat. Application of a new radiometric high performance liquid chromatography assay. Drug Metab. Dispos. 16, 125-129.
14. Dow, J., and Berg, C. (1995) Stereoselectivity of the carbonyl reduction of dolasetron in rats, dogs, and humans. Chirality 7, 342-348.
15. Schwartz, S. L., and McKennis, H., Jr. (1963) Studies on the degradation of the pyrrolidine ring of (-)-nicotine in vivo. Formation of γ-(3-pyridyl)-γ-oxobutyric acid. J. Biol. Chem. 238, 1807-1812.
16. Schwartz, S. L., and McKennis, H. (1964) Mammalian degradation of (-)-demethylcotinine. Nature 202, 594-595.
17. Wada, E., and Yamasaki, K. (1954) Degradation of nicotine by soil bacteria. J. Am. Chem. Soc. 76, 155-157.
18. Wada, E. (1957) Microbial degradation of the tobacco alkaloids and some related compounds. Arch. Biochem. Biophys. 72, 145-162.
19. Hylin, J. W. (1959) The microbial degradation of nicotine II. The mode of action of Achromobacter nicotinophagum. Arch. Biochem. Biophys. 83, 528-537.
20. Frankenberg, W. G. (1955) Nicotine degradation in vitro induced by agents from tobacco seed. Nature 175, 945-946.